Yahoo
NasdaqGS - Delayed Quote USD

Indivior Pharmaceuticals, Inc. (INDV)

34.94 +0.11 (+0.32%)
At close: September 4 at 4:00:01 PM EDT
34.94 0.00 (0.00%)
After hours: September 4 at 7:30:03 PM EDT
Trade INDV on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
1,331,000
1,239,000
1,188,000
1,093,000
901,000
Cost of Revenue
240,000
246,000
231,000
174,000
151,000
Gross Profit
1,091,000
993,000
957,000
919,000
750,000
Operating Expense
667,000
728,000
723,000
672,000
535,000
Operating Income
424,000
265,000
234,000
247,000
215,000
Net Non Operating Interest Income Expense
-10,000
-23,000
-18,000
8,000
-8,000
Other Income Expense
--
-3,000
--
-401,000
-296,000
Pretax Income
394,000
239,000
20,000
-145,000
-89,000
Tax Provision
38,000
29,000
13,000
-19,000
-44,000
Net Income Common Stockholders
356,000
210,000
7,000
-126,000
-44,000
Diluted NI Available to Com Stockholders
356,000
210,000
7,000
-126,000
-44,000
Basic EPS
2.88
1.68
-0.36
0.01
-0.38
Diluted EPS
2.79
1.64
-0.36
0.01
-0.38
Basic Average Shares
123,500
125,000
132,309
137,306
139,012
Diluted Average Shares
129,000
128,048.78
132,309
141,800
145,617
Total Operating Income as Reported
421,000
262,000
38,000
-152,000
-81,000
Total Expenses
907,000
974,000
954,000
846,000
686,000
Net Income from Continuing & Discontinued Operation
356,000
210,000
7,000
-126,000
-44,000
Normalized Income
374,974.62
212,634
161,840
222,455.17
189,840
Interest Income
17,000
22,000
23,000
43,000
19,000
Interest Expense
27,000
45,000
41,000
35,000
27,000
Net Interest Income
-10,000
-23,000
-18,000
8,000
-8,000
EBIT
421,000
284,000
61,000
-110,000
-62,000
EBITDA
438,000
304,000
89,000
-95,000
-46,000
Reconciled Cost of Revenue
240,000
246,000
231,000
174,000
151,000
Reconciled Depreciation
17,000
20,000
28,000
15,000
16,000
Net Income from Continuing Operation Net Minority Interest
356,000
210,000
7,000
-126,000
-44,000
Total Unusual Items Excluding Goodwill
-21,000
-3,000
-196,000
-401,000
-296,000
Total Unusual Items
-21,000
-3,000
-196,000
-401,000
-296,000
Normalized EBITDA
459,000
307,000
285,000
306,000
250,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-2,025.38
-366
-41,160
-52,544.83
-62,160
12/31/2022 - 12/29/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: